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Amber L Nolan and Kuang-Yu Jen*Abstract
Rheumatic manifestations of cocaine have been well described, but more recently, a dramatic increase in the
levamisole-adulterated cocaine supply in the United States has disclosed unique pathologic consequences that
are distinct from pure cocaine use. Most notably, patients show skin lesions and renal dysfunction in the setting
of extremely high perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA). Unexpectedly, antibodies to
myeloperoxidase, the typical target of p-ANCA, are relatively low if at all present. This discrepancy is due to the
fact that p-ANCA seen in association with levamisole-adulterated cocaine exposure is often directed against
atypical p-ANCA-associated antigens within the neutrophil granules such as human neutrophil elastase, lactoferrin,
and cathepsin G. Biopsies of the skin lesions reveal leukocytoclastic vasculitis often involving both superficial and
deep dermal vessels. Renal injury most typically manifests as crescentic and necrotizing pauci-immune glomerulonephritis.
In this review, the manifestations of levamisole-adulterated cocaine-induced vasculitis are discussed with an emphasis on
the typical histomorphologic findings seen on biopsy.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
1764738711370019.
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Rheumatic consequences of cocaine are rare but well
documented. These disorders primarily manifest as
organ specific vasculitis (such as cerebral vasculitis),
systemic vasculitis, or cocaine-induced midline destruc-
tive lesions (CIMDL) [1]. In the case of cocaine-induced
systemic vasculitis, the clinical and laboratory findings
are essentially indistinguishable from primary, idiopathic
granulomatosis with polyangiitis (GPA), which is charac-
terized by skin lesions, nasal and palate destruction,
pauci-immune glomerulonephritis with crescents and/or
necrotizing lesions, and positive laboratory test for cyto-
plasmic antineutrophil cytoplasmic antibodies (c-ANCA)
associated with proteinase-3 (PR3) antibodies [2-4].
CIMDL can closely mimic the upper airway lesions seen
in GPA with reports ranging from severe sinusitis to
nasal and palatal perforation; however, the pathophysi-
ology is thought to be secondary to chronic cocaine* Correspondence: kuangyujen@ucsf.edu
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unless otherwise stated.exposure, leading to progressive mucosal and perichon-
drial injury and subsequent ischemic necrosis and
perforation of the nasal septum [5,6]. Histologically,
CIMDL is distinguished from GPA by the lack of granu-
lomatous inflammation and vasculitis on biopsy, and
serologic differences have been reported [7,5,8,9]. While
these pathologies are rare, it is important to recognize
the association with cocaine use, as cessation of the drug
is often the only treatment needed.
Since 2005, a new vasculitic syndrome appears to be oc-
curring with increasing frequency in patients who use co-
caine, characterized by positive perinuclear (p)-ANCA
serologies, neutropenia/agranulocytosis, and purpuric
lesions involving the face, especially the ear lobes, with
varying frequencies of glomerulonephritis and lung
hemorrhage. The increased prevalence appears to be cor-
related with the escalating abuse of levamisole-adulterated
cocaine [1]. This review will summarize the range of clin-
ical and pathologic findings seen in the setting of
levamisole-adulterated cocaine exposure with an emphasis
on the morphologic features observed in patient biopsies.al. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Levamisole and levamisole-adulterated cocaine
Levamisole, a synthetic imidazothiazole derivative, is an
anti-helminthic drug with immunomodulatory activity,
which has been used in the past to treat a variety of con-
ditions including malignancy, autoimmune disorders
such as rheumatoid arthritis, and pediatric nephrotic
syndrome [10-12]. It was removed from the United States
market for human use in 1999 due to significant side
effects including agranulocytosis and thrombocytopenia
[13-15]. Chronic use of levamisole is associated with posi-
tive ANCA serologies and a characteristic skin rash of
retiform purpura involving the ears, face, and extremities.
Accompanying skin biopsies often show leukocytoclastic
vasculitis [16,17].
Levamisole-adulterated cocaine has been increasing in
frequency in the United States drug supply since 2005
with a prevalence now estimated at up to 70-80% of the
cocaine entering the country [18-20]. It has not been
clearly elucidated as to why this compound has become
such a common additive in cocaine, but several explana-
tions have been proposed. Levamisole may inhibit
monoamine oxidase and catechol-O-methyltransferase,
potentiating the level of dopamine in the central ner-
vous system and leading to a higher activation of the
reward system [21,22]. Furthermore, in the muscle cells
of helminthes, this drug blocks nicotinic acetylcholine
receptors; a similar action in humans may have a second-
ary effect on the release of dopamine [22,21]. A metabolite
of levamisole, aminorex, could have amphetamine-like
stimulant properties as well, or may act indirectly as a
serotonin receptor agonist [21,13]. Alternatively, levami-
sole may purely be used as a cutting agent to add volume
while maintaining a white powdery consistency [21]. Re-
gardless of the reason, increasing levamisole-associated
pathology is being identified across the country and prompt
recognition of a few characteristic features may help guide
treatment and prevent further long-term complications.
Signs and symptoms
Patients with symptoms of levamisole-associated vasculitis
due to cocaine exposure often experience nonspecific con-
stitutional symptoms such as fever, fatigue, flu-like symp-
toms, night sweats, and weight loss. Arthralgia and
cutaneous manifestations are also quite common clinical
findings and often motivate the individual to seek medical
care [23]. Additionally, extra-cutaneous involvement may
be present (detailed below).
Anti-neutrophil cytoplasmic antibodies and other
serologies
Patients with vasculitis associated with levamisole-
adulterated cocaine classically demonstrate unique sero-
logic abnormalities characterized by unusually high titersof p-ANCA without substantial antibodies against mye-
loperoxidase (MPO), the typical target of p-ANCA. This
conflicting finding is due to high titer p-ANCA produc-
tion that is often directed against atypical p-ANCA-
associated antigens within the neutrophil granules such
as human neutrophil elastase (HNE), lactoferrin, and
cathepsin G [1,24]. Such serologic findings are character-
istic of levamisole-associated autoimmune disease but
not specific to this entity since similar serologic profiles
can be encountered in other drug-induced ANCA-
associated vasculitides [25].
Interestingly, some p-ANCA-positive patients with
levamisole-adulterated cocaine exposure may show the
presence of anti-PR3 antibodies, which typically are c-
ANCA. Some speculate that this discordant observation
may be due to cross-reactivity of the antibodies against
homologous epitopes on PR3 and HNE [1]. In addition,
the majority of cases are also positive for antiphospholipid
antibodies such as lupus anticoagulant and anti-
cardiolipin antibody as well as antinuclear and anti-
double-stranded DNA antibodies [24]. These features can
help distinguish levamisole-adulterated cocaine-induced
pathology from idiopathic ANCA-associated vasculitis,
which may present with a similar clinical picture but
would demonstrate lower ANCA titers with specific anti-
bodies to one neutrophilic antigen rather than several.
Pure cocaine use can also provoke ANCA-associated
vasculitis. However, cocaine-induced GPA demonstrates
positive c-ANCA and PR3 antibody in contrast to the p-
ANCA predominant pattern seen with levamisole [2].
Antiphospholipid antibodies have not been reported in
patients with pure cocaine-associated autoimmune
disease [26,24].Hematological abnormalities
Levamisole-adulterated cocaine was originally brought
to clinical attention after several case reports of severe
agranulocytosis associated with cocaine use emerged in
a clinical reference laboratory in New Mexico [7,20].
Morphologic analysis of the bone marrow and blood
demonstrated increased plasmacytoid lymphocytes, bone
marrow plasmacytosis, and megakaryocyte hyperplasia
with increased frequency in the cocaine-exposed agran-
ulocytosis group [20]. In small studies, neutropenia was
reported with an incidence of 4.2% in cocaine users in
general and an incidence of 2.1% in users with docu-
mented exposure to levamisole and cocaine [27]. In a
retrospective analysis investigating patients with expos-
ure to cocaine in addition to high p-ANCA titers or
combined positivity for MPO and PR3 antibodies, 28%
had leukopenia, of which half had an absolute neutrophil
count of <1000 [23]. These findings are compatible with
the toxicity levels seen with levamisole use alone where 2.5-
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which occurs in a dose-dependent fashion [14,28,29,15].
Interestingly, neutropenia/agranulocytosis is a feature
not commonly associated with pure cocaine-linked rheu-
matologic disease, and is not reported as a general char-
acteristic of a drug-induced ANCA-associated vasculitis
[30]. Thus, this hematologic abnormality may be a clue
to suspect levamisole-induced pathology.
Skin pathology
Another distinguishing finding of levamisole-adulterated
cocaine-induced pathology is characteristic skin lesions,
which often involve the ear lobes and the skin overlying
the zygomatic arch [24]. Other frequent areas of involve-
ment include the extremities, particularly the lower
extremities, with relative sparing of the trunk and back
[31,24,32]. The rash often presents as purpuric plaques
with a retiform pattern in half of patients and central
necrosis in a third of patients [31]. In individuals with
skin lesions, associated hematological abnormalities
occur in approximately 60%, while 95-100% of patients
have positive ANCA serologies [24,31].
Biopsies of the skin lesions generally show small vessel
vasculitis in the form of leukocytoclastic vasculitis, with
or without intravascular thrombi [31,33,24,32] (Figure 1).
Typically, both superficial and deep small dermal vessels
are involved by angiocentric mixed inflammatory cell
infiltrates prominent in neutrophils, and at times also
frequent in eosinophils. The inflammation infiltrates the
vascular walls and into the perivascular zones and usu-
ally shows prominent leukocytoclastic debris (nuclear
dust). Fibrinoid necrosis of vascular walls can be seen
and often extends into the adjacent perivascular
connective tissue. Extravasation of red blood cells is also
a common histologic finding. Direct immunofluores-
cence may highlight antibody and complement depos-
ition in vessel walls [31]. These findings are similar to
reports from chronic levamisole use in pediatric patients
treated for nephrotic syndrome; in one case series, 5 of
160 children developed purpura on at least the ears withFigure 1 Skin biopsy from a patient with exposure to levamisole-adu
superficial and deep dermal vessels (hematoxylin and eosin stain, 40X). B) Nu
walls associated with leukocytoclastic debris and fibrinoid necrosis (hematoxybiopsies revealing cutaneous vasculitis or thrombotic
lesions [17]. The cutaneous lesions observed in ANCA-
associated systemic vasculitis typically demonstrate simi-
lar histopathology of leukocytoclastic vasculitis; however,
the predilection for the ears and zygomatic arch appears
to represent a discriminating feature with levamisole-
adulterated cocaine exposure [24,30].
Renal pathology
Despite sharing many features with other drug-induced
ANCA-associated vasculitides, organ involvement is not
commonly discussed with levamisole-adulterated
cocaine-induced autoimmune disease. However, recent
case reports suggest that this aspect may have been
overlooked. In a retrospective analysis investigating
patients with unusually high p-ANCA titers and expos-
ure to cocaine, eight out of thirty patients were reported
to have proteinuria or hematuria, and two developed
acute kidney injury [23]. One patient underwent renal
biopsy showing focal necrotizing and crescentic pauci-
immune glomerulonephritis. In another case report, a
45-year-old man presented with characteristic necrotic
skin lesions and an associated positive ANCA serology
as well as a positive toxicology screen for cocaine and
levamisole on mass spectrometry. He displayed both
hematuria and proteinuria, was treated with prednisone,
and left against medical advice. Seven months later, he
presented after repeat cocaine use with acute on chronic
renal insufficiency and a renal biopsy displaying necrotiz-
ing and crescentic pauci-immune glomerulonephritis [34].
In a review of an inner city hospital’s pauci-immune
glomerulonephritis cases over a two-year period, four
patients were identified with disease who had exposure
to cocaine, serologies compatible with levamisole expos-
ure, and one other common clinical indicator of levami-
sole exposure (purpura, digital infarcts, or neutropenia)
[35]. These biopsies demonstrated a range of glomerular
crescents from cellular to fibrocellular to fibrous cres-
cents, reflecting the relative timeframe of levamisole-
adulterated cocaine exposure in relation to time oflterated cocaine. A) Leukocytoclastic vasculitis involves both
merous neutrophils and eosinophils surround and involve the vascular
lin and eosin stain, 400X).
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necrotizing lesions (Figure 2). Patchy acute tubular epi-
thelial cell injury was commonly noted, and one case
with mostly fibrous/fibrocellular crescents exhibited
significant interstitial fibrosis and tubular atrophy. Ves-
sels showed the typical chronic changes seen in associ-
ation with age and drug use, but no evidence of
malignant hypertension or thrombotic microangiopathy
was detected. Immunofluorescence stains for immuno-
globulins (IgG, IgM, and IgA) and complement compo-
nents (C3 and C1q) were negative in all cases. Electron
microscopy confirmed the lack of immune complex
deposition. Thus, these features were classified as cres-
centic and necrotizing pauci-immune glomerulonephritis.
These reports suggest a role for levamisole-adulterated
cocaine in the induction of pauci-immune glomerulo-
nephritis. In the kidney, pure cocaine use without an
autoimmune syndrome most commonly leads to severe
intimal thickening of arteries reflecting accelerated
arteriosclerosis. Rare cases of thrombotic microangiopa-
thy due to malignant hypertension and renal infarction
have been reported [36-38]. Cocaine-induced GPA with
a positive c-ANCA serology can be associated with a
pauci-immune glomerulonephritis [2,4,3]. Interestingly,
glomerulonephritis is not a reported complication of
levamisole-use alone, and this pathology may represent a
synergistic effect of cocaine and levamisole.
Pulmonary pathology
As with other drug-induced vasculitides, which are
known to involve a triad of skin, kidney and lung,
pulmonary pathology is occasionally reported with
levamisole-adulterated cocaine exposure. Diffuse al-
veolar hemorrhage, requiring intubation, was reported
in one patient who also had concurrent pauci-
immune glomerulonephritis [35]. Three out of thirty
patients with cocaine exposure and high p-ANCA
antibodies developed pulmonary hemorrhage not re-
quiring intubation; none of these patients hadFigure 2 Kidney biopsy from a patient with exposure to levamisole-a
presence of fibrin (arrow) within the Bowman space with associated nuclear
B) Cellular crescent with fibrin (arrow) within the Bowman space (methenami
otherwise relatively normal, as is often seen in pauci-immune glomerulonephconvincing coexisting renal disease [23]. Aminorex, a
metabolite of levamisole, has been associated with one
case of idiopathic pulmonary hypertension [39]. No biop-
sies have been reported to further characterize this associ-
ated lung pathology, and no specific upper airway lesions
have been identified or discussed with this syndrome.
Mechanisms of levamisole-adulterated cocaine-induced
pathology
The mechanism whereby levamisole-adulterated cocaine
leads to vasculitis, glomerulonephritis, and agranulocyto-
sis is unclear, but several theories have been proposed.
As with other drug-induced ANCA-associated vasculit-
ides, the mechanism is hypothesized to be a direct con-
sequence of the anti-neutrophilic antibodies. Several
clinical observations support this theory in typical
ANCA-associated vasculitis. First, antibody titers appear
to correlate with disease relapse [40,41]. Furthermore,
treatment with B-cell depleting rituximab successfully
treats symptoms of ANCA-associated disease [30]. Add-
itionally, transplacental MPO-ANCA was directly associ-
ated with kidney and lung disease in a neonate, which
resolved shortly after birth [42,43]. Animal models also
exhibit pauci-immune glomerulonephritis and small
vessel vasculitis after development of antibodies to
MPO. The proposed mechanism supports that priming
of neutrophils leads to translocation of ANCA antigens
to the cell surface. In the presence of ANCA, such anti-
gens lead to further neutrophil activation and increased
adherence and migration of neutrophils through the
endothelium. In addition, release of reactive oxidative
species and neutrophil degranulation causes small vessel
destruction [30]. T-cell-mediated immunity is also crit-
ical to disease development. In mouse models, T-cell
depletion inhibits vasculitis, and a MPO T-cell epitope is
essential for glomerular injury [44,30].
How these antibodies develop is also under much
investigation. A predisposition to autoimmune disease is
associated with levamisole-induced pathology, as theredulterated cocaine. A) Necrotizing lesion characterized by the
debris and incipient cellular crescent (hematoxylin and eosin stain, 400X).
ne silver-Periodic acid-Schiff stain, 400X). Note that the glomerular tuft is
ritis.
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with rheumatic disease, and patients carrying the HLA
B27 genotype [20]. Levamisole may interact with neutro-
phil extracellular traps (NETs), which are composed of a
complex of DNA, histones and neutrophil granules in-
cluding MPO, PR3, and HNE. NETs could be released in
response to stress and provide a source of antigen that
could activate the immune system. Certain medications,
such as propylthiouracil, are correlated with disorga-
nized NET structure, promoting prolonged degradation
and possible antigenicity [45]. Some drugs may also
accumulate in neutrophils and bind to MPO, causing
production of a subsequent auto-antigen; drug-induced
neutrophil apoptosis may also overstimulate the immune
system [30].
The reactive electrophile has specifically been put
forth as a mechanism for drug-mediated agranulocytosis.
More specifically, it has been hypothesized that an elec-
trophilic reactive metabolite of levamisole may act as a
hapten and react with a self-peptide to generate an
immune response. Subsequently, T-cell activation occurs
and results in a delayed hypersensitivity reaction,
which fits with the clinical timeframe for levamisole-
induced agranulocytosis [46]. A similar hypothesis has
also been described for other drugs, such a pro-
pylthiouracil, with side effects including agranulocyto-
sis and drug-induced vasculitis.Conclusion
In summary, levamisole-adulterated cocaine use is a
growing public health concern. It is associated with an
autoimmune syndrome that typically presents with non-
specific flu-like symptoms, neutropenia/agranulocytosis,
high titers of several p-ANCA antibodies, and a charac-
teristic rash of retiform purpura with possible necrosis
involving the ears, face and extremities. Organ involve-
ment also appears to be possible with several case
reports of both renal and lung disease that is most com-
monly expressed as pauci-immune glomerulonephritis
and pulmonary hemorrhage, respectively. The mechan-
ism of disease is still under investigation but hinges on
drug-induced production of auto-antibodies. Treatment
depends on the organ systems involved. Patients with this
condition may require less immunosuppressive medica-
tion compared to idiopathic vasculitides since cessation of
drug use appears to lead to drastic improvements.
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